Effect of Butylated Hydroxyanisole on Hepatic Glucuronidation and Biliary Excretion of Drugs in Mice

ZOLTAN GREGUS, CURTIS D. KLAASSEN

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Abstract— Inhibition of glucuronidation by depletion of UDP‐glucuronic acid from liver impairs the hepatobiliary transport of glucuronidated xenobiotics. However, it is not known if enhancement of hepatic glucuronidation increases the biliary excretion of these compounds. Therefore, the effect of treatment with butylated hydroxyanisole (BHA), which increases hepatic glucuronidation capacity, on the biliary excretion of compounds undergoing glucuronidation was studied in mice. BHA‐feeding (1% for 10 days) increased hepatic UDP‐glucuronic acid content by 240% and enhanced hepatic UDP‐glucuronosyltransferase activities (expressed per kg body weight) toward valproic acid, phenolphthalein, iopanoic acid and bilirubin 220, 180, 120 and 60%, respectively. BHA treatment did not influence the biliary excretion of unmetabolized cholephils, phenol‐3,6‐dibromphthalein disulphonate and phenolphthalein glucuronide, but enhanced that of phenolphthalein (+108%), iopanoic acid (+63%) and bilirubin (+33%) as glucuronides. However, these increases were apparent only in the initial phase of excretion. In contrast, BHA markedly decreased (−43%) the biliary excretion of valproic acid glucuronides. Simultaneously, BHA increased the urinary excretion of the glucuronides of phenolphthalein (+48%), iopanoic acid (+450%) and valproic acid (+150%). A shift in the distribution of iopanoic acid and valproic acid and metabolites from liver to kidney was also apparent in BHA‐fed mice. Thus, enhanced glucuronidation does not facilitate the biliary excretion of all glucuronidated compounds and only transiently increases others. It is likely that this phenomenon is the result of the glucuronides readily entering the plasma and being excreted by the kidney. 1988 Royal Pharmaceutical Society of Great Britain

Original languageEnglish
Pages (from-to)237-242
Number of pages6
JournalJournal of Pharmacy and Pharmacology
Volume40
Issue number4
DOIs
Publication statusPublished - Apr 1988

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'Effect of Butylated Hydroxyanisole on Hepatic Glucuronidation and Biliary Excretion of Drugs in Mice'. Together they form a unique fingerprint.

  • Cite this